ADORA2A and sarcoma: While data from our lab and others show that A2aR blockade during initial T cell activation can greatly enhance T cell expansion and generation of memory phenotypes, studies by Ohta et al. show that A2aR blockade during adoptive T cell therapy in sarcoma models has a role in enhancing T cell effector function as well [4].